RE:RE:RE:RE:RE:RE:RE:RE:RE:Pfizer Pfizer will now build up its biologics business, newly appointed Chief Oncology Officer Chris Boshoff said in a statement, adding that this strategic positioning—combined with several “significant catalysts” starting in 2025—will help Pfizer’s oncology franchise be a “critical driver of potential long-term sustainable sales and profit growth” for the company.